EPO Patents = 2

Forward Citations = 2

Loading Chart...

5 inventors (with patents filed for the assignee):

Hai Yan (10 out of 37 patents)

Frank J Calzone (6 out of 22 patents)

John Zhang (5 out of 5 patents)

4. Jim Shi (3 out of 3 patents)

5. Jeong Oh (1 out of 1 patent)

12 patents: Sort by Forward Citations

1. 12617857 - CHEMOKINE RECEPTOR 4 (CXCR4) ANTAGONIST ANTIBODIES (2026-05-05),

2. 11629184 - Calcitonin gene-related peptide (CGRP) antagonist antibodies (2023-04-18),

3. 11447555 - Methods for treating type 1 diabetes using glucagon receptor antagonistic antibodies (2022-09-20),

4. 11446376 - Methods for treating heart failure using glucagon receptor antagonistic antibodies (2022-09-20),

5. 11332531 - Immunotherapy using antibodies that bind programmed death ligand-1 (PD-L1) (2022-05-17),

6. 11319376 - Combination of glucagon receptor antagonists and PI3K pathway inhibitors for the treatment of cancer (2022-05-03),

7. 11319372 - Cancer treatment using antibodies that bind cytotoxic T-lymphocyte antigen-4 (CTLA-4) (2022-05-03),

8. 11248049 - Immunotherapy using antibodies that bind Programmed Death 1 (PD-1) (2022-02-15),

9. 11242398 - Anti-OX40 antibodies and methods of activating OX40 (2022-02-08),

10. 10765737 - Methods for treating heart failure using glucagon receptor antagonistic antibodies (2020-09-08),

11. 10752693 - Methods for treating obesity and nonalcoholic fatty liver disease or nonalcoholic steatohepatitis using glucagon receptor antagonistic antibodies (2020-08-25),

12. 10626179 - Methods for treating type 1 diabetes using glucagon receptor antagonistic antibodies (2020-04-21),

Company Overview

Remd Biotherapeutics, Inc. is a biotechnology company based in Camarillo, California, specializing in the development of innovative therapeutics for various medical conditions. The organization focuses on harnessing advanced biopharmaceutical technologies to create novel treatments that address unmet medical needs. With a commitment to research and development, Remd Biotherapeutics aims to improve patient outcomes through its cutting-edge solutions in the biotherapeutics domain.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

12 Patents

#23 in Camarillo, CA

#6,060 in California

#25,540 in US

#48,129 in the World

Camarillo, CA, United States of America

Remd Biotherapeutics, Inc.

Forward Citations = 2

5 inventors:

Hai Yan (10 out of 37 patents)

Frank J Calzone (6 out of 22 patents)

John Zhang (5 out of 5 patents)

4. Jim Shi (3 out of 3 patents)

5. Jeong Oh (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Remd Biotherapeutics, Inc.. Retrieved from https://idiyas.com/company/remd-biotherapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]